95 related articles for article (PubMed ID: 6750185)
1. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on arterial blood pressure].
Watanabe H
Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):405-19. PubMed ID: 6750185
[No Abstract] [Full Text] [Related]
2. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
3. [Angiotensin converting enzyme--captopril].
Kaneko Y; Shionoiri H; Uneda S; Fujishima S
Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
[No Abstract] [Full Text] [Related]
4. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme].
Waeber B; Gavras H; Brunner HR; Chappuis P; Turini GA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1981-3. PubMed ID: 219469
[TBL] [Abstract][Full Text] [Related]
5. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
6. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
8. [Captopril (oral inhibitor of angiotensin I converting-enzyme) in arterial hypertension].
Simonetti BM; Manzi M; Feriozzi S; Pierucci A
Clin Ter; 1982 Jul; 102(1):67-83. PubMed ID: 6754215
[No Abstract] [Full Text] [Related]
9. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
10. [Effect of captopril in essential hypertension (author's transl)].
Mimran A; Targhetta R; Laroche B
Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
[TBL] [Abstract][Full Text] [Related]
11. [Use of captopril in arterial hypertension with a stable and malignant course].
Lordkipanidze NL
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
[No Abstract] [Full Text] [Related]
12. [Long term treatment of resistant hypertension with captopril (author's transl)].
Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
[TBL] [Abstract][Full Text] [Related]
13. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
14. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
[No Abstract] [Full Text] [Related]
15. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
Walter NM; Whitworth JA; Kincaid-Smith P
Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
[No Abstract] [Full Text] [Related]
17. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].
Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K
Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493
[No Abstract] [Full Text] [Related]
18. [A case of bilateral renovascular hypertension controlled by angiotensin converting enzyme inhibitor (captopril) after arterioplasty for predominantly stenotic side (author's transl)].
Sakoda H; Ohashi H; Yoshida H; Morimoto K; Kawai C; Hara A; Matsunaga M; Kawamura J; Kumada K
Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):167-73. PubMed ID: 7047823
[No Abstract] [Full Text] [Related]
19. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
Overlack A; Stumpe KO; Heck I; Krück F
Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
[TBL] [Abstract][Full Text] [Related]
20. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
Aberg H; Frithz G; Mörlin C
Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
